U.S. adults impression of the U.S. pharma companies transparency
This statistic shows the results of a survey conducted in the United States in February 2017. U.S. adults were asked to rate U.S. pharmaceutical companies concerning their transparency. In total, 10 percent of respondents indicated that the U.S. pharma companies had excellent transparency, while 41 percent indicated that they had insufficient transparency.